Trials / Conditions / Mucocutaneous Leishmaniasis
Mucocutaneous Leishmaniasis
3 registered clinical trials studyying Mucocutaneous Leishmaniasis.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Dedicated QT Study in Bolivian Patients Taking Impavido® (Miltefosine) for Mucocutaneous Leishmaniasis NCT02429518 | Knight Therapeutics (USA) Inc | — |
| Completed | Spermiogram Assessment in Bolivian Patients Taking Impavido® (Miltefosine) for Mucocutaneous Leishmaniasis NCT02431429 | Knight Therapeutics (USA) Inc | — |
| Unknown | Low Antimonial Dosage in American Mucosal Leishmaniasis NCT01301937 | Oswaldo Cruz Foundation | Phase 2 / Phase 3 |